Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins
Nicole L. Jarvi, Sathy V. Balu‐Iyer
BioDrugs (2021) Vol. 35, Iss. 2, pp. 125-146
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Designing antibodies as therapeutics
Paul J. Carter, Arvind Rajpal
Cell (2022) Vol. 185, Iss. 15, pp. 2789-2805
Open Access | Times Cited: 137
Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery
Yisi Tang, Bao Liu, Yuting Zhang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115304-115304
Closed Access | Times Cited: 18
Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis?
Wim Jiskoot, Andrea Hawe, Tim Menzen, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 111, Iss. 4, pp. 861-867
Open Access | Times Cited: 64
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Emerson A. Lim, Michael T. Schweizer, Kim N., et al.
Clinical Genitourinary Cancer (2023) Vol. 21, Iss. 3, pp. 366-375
Open Access | Times Cited: 29
Subcutaneous drug delivery from nanoscale systems
Lorenzo Tomasini, Marianne Ferrere, Julien Nicolas
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 6, pp. 501-520
Closed Access | Times Cited: 10
Clinical perspective on topical vaccination strategies
Petya Popova, Sunny P. Chen, Suiyang Liao, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115292-115292
Open Access | Times Cited: 8
Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases
Óscar Pizano-Martínez, Edgar Mendieta-Condado, Mónica Vázquez-Del Mercado, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 9, pp. 3271-3271
Open Access | Times Cited: 20
Engineered therapeutic proteins for sustained-release drug delivery systems
Thoa Thi Kim Nguyen, Khang‐Yen Pham, Simmyung Yook
Acta Biomaterialia (2023) Vol. 171, pp. 131-154
Open Access | Times Cited: 19
Biomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation
Amogh Gorantla, Jacques Hall, Anneliese Troidle, et al.
Micromachines (2024) Vol. 15, Iss. 4, pp. 533-533
Open Access | Times Cited: 6
Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy
Padakanti Sandeep Chary, Samia Shaikh, Naveen Rajana, et al.
Biomaterials Advances (2024) Vol. 162, pp. 213903-213903
Closed Access | Times Cited: 6
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine
Johanna Elin Gehin, Guro Løvik Goll, Marthe Kirkesæther Brun, et al.
BioDrugs (2022) Vol. 36, Iss. 6, pp. 731-748
Open Access | Times Cited: 24
Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
Brian G. Feagan, Stefan Schreiber, Anita Afzali, et al.
Contemporary Clinical Trials (2022) Vol. 122, pp. 106958-106958
Open Access | Times Cited: 23
Subcutaneous Administration of a Zwitterionic Chitosan‐Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies
Thomas Gréa, Guillaume Jacquot, Arthur Durand, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Open Access | Times Cited: 15
Survey Outcome on Immunogenicity Risk Assessment Tools for Biotherapeutics: an Insight into Consensus on Methods, Application, and Utility in Drug Development
Jochem Gokemeijer, Yi Wen, Vibha Jawa, et al.
The AAPS Journal (2023) Vol. 25, Iss. 4
Closed Access | Times Cited: 14
Monoclonal antibody and protein therapeutic formulations for subcutaneous delivery: high-concentration, low-volume vs. low-concentration, high-volume
Mukesh Desai, Amit Kundu, Michiel Hageman, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Subcutaneous Administration of Therapeutic Monoclonal Antibody Drug Products Using a Syringe in Blinded Clinical Trials: Advances and Key Aspects Related to Blinding/Matching/Masking Strategies for Placebo Formulation
Kashappa Goud H. Desai
Molecular Pharmaceutics (2025)
Closed Access
Local delivery strategies to restore immune homeostasis in the context of inflammation
Elizabeth R. Bentley, Steven R. Little
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113971-113971
Open Access | Times Cited: 28
Macro-microporous ZIF-8 MOF complexed with lysosomal pH-adjusting hexadecylsulfonylfluoride as tumor vaccine delivery systems for improving anti-tumor cellular immunity
Qinhua Zuo, Tiantian Li, Linghong Huang, et al.
Biomaterials Science (2023) Vol. 11, Iss. 14, pp. 5025-5045
Closed Access | Times Cited: 12
Evaluation of the impact of repeated intravenous phage doses on mammalian host–phage interactions
Xin Tan, Kai Chen, Zhihuan Jiang, et al.
Journal of Virology (2023) Vol. 98, Iss. 1
Open Access | Times Cited: 12
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
Ole Haagen Nielsen, Alexander Hammerhøj, Mark Ainsworth, et al.
Drugs (2024)
Closed Access | Times Cited: 4
Evaluating the Immunogenicity Risk of Protein Therapeutics by Augmenting T Cell Epitope Prediction with Clinical Factors
Zicheng Hu, Patrick Wu, Steven J. Swanson
The AAPS Journal (2025) Vol. 27, Iss. 1
Open Access
Nonshrinkable Thermosensitive Hydrogels Combined with Bispecific Anti-PSMA/CD3 T-Cell Engager for Effective Against Tumors in Mice Model
Pu-Sheng Wei, Po-Yu Chou, Hong‐Yuan Hsu, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3083-3111
Open Access
PM2.5 Stimulates Macrophage-Derived Thymic Stromal Lymphopoietin (TSLP) to Induce a Mouse Model of Allergic Conjunctivitis
Ya-Zhou Qin, Yue Bian, Jingbo Hu, et al.
Current Eye Research (2025), pp. 1-11
Closed Access
Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study
Ronald van Vollenhoven, Bevra H. Hahn, George C. Tsokos, et al.
The Journal of Rheumatology (2021) Vol. 49, Iss. 4, pp. 380-387
Open Access | Times Cited: 25
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access
Beate Bittner, Johannes Schmidt
BioDrugs (2023) Vol. 38, Iss. 1, pp. 23-46
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top